Pricing Log in Create free account
Friday 6 November 2026 Export CCLD’s income statement to Excel — free account

CareCloud, Inc.

CCLD Healthcare Health Information Services

CareCloud, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.5 million, up 8.72% from fiscal 2024.

Revenue
+8.56%
EPS
+150.0%
Free cash flow
−0.44%
Total debt
+44,345.3%

Quarter to September 2026, against a year earlier

2.31 0.15 +6.94%
Market cap
$91.8M
P/E
16.5×
Fwd P/E
11.0×
Dividend yield
—
F-score
6/9
Altman Z
3.29
Beneish M
−3.25
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 15.80%

Capital & Financial Ratios $m

Size
Market Cap 91.79
Revenue ttm 131.30
Net income ttm 9.66
Free cash flow ttm 25.00
Net debt Q (4.64)
Valuation
P/E 16.54
Forward P/E 11.00
Price / sales 0.70
Forward P/S Powerpack
Price / FCF 5.11
Price / book 4.04
Financial health
Current ratio Q 0.87 (below 1: weak)
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q 3.65
Growth
Revenue growth Q +8.56% (above 0%: growing)
Operating income growth Q +104.83% (above 0%: growing)
EPS, this year +175.00% (at or above 15%: strong)
EPS, next year A +10.91%
Revenue, next year A +8.13%
EPS, past 5 yrs —
EPS, next 5 yrs A +62.03% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.0×, against a ten-year median of 0.6×; over the ten years it ranged from 0.2× in 2023 to 1.8× in 2020.
P/S against its own 10 years 49.61%
10-year low 10-year high
P/B against its own 10 years 96.63%
10-year low 10-year high
EV/Sales against its own 10 years 75.06%
10-year low 10-year high
EV/FCF against its own 10 years 55.33%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 3 5 4 5
Receivables 12 13 15 17
Inventory 0 1 1 1
Other 5 4 4 3
23 25 26 28
2023 2024 2025 Q'26
Payables 6 5 7 6
ST’ Debt — — — —
Other — — 1 0
23 20 24 33

Compound Annual Growth %

10y 5y 3y
Sales 17.97% 2.77% (4.61%)
Cash Flow 0.00% 0.00% 10.53%
Earnings 0.00% 0.00% 0.00%
Book Value 14.86% (10.08%) (16.36%)

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 0.07 Actual 0.06

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 0.08 0.10 Beat by 0.02
Q4 FY25 0.11 0.11 Met by 0.00
Q1 FY26 0.06 0.05 Miss by 0.01
Q2 FY26 0.07 0.06 Miss by 0.01
Q3 FY26 0.12 — Reports 5 November 2026

EPS $

Mar Jun Sep Dec Year
’26 (0.01) 0.00 0.10 — —
’25 (0.04) 0.04 0.04 0.04 0.10
’24 (0.02) (0.14) (0.04) 0.00 (0.28)
’23 (0.28) (0.37) (0.42) (3.00) (4.11)
’22 (0.19) (0.07) (0.18) (0.22) (0.67)
’21 (0.36) (0.27) (0.15) (0.01) (0.77)
’20 (0.42) (0.65) (0.46) 0.01 (1.79)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 31 32 34 — —
’25 28 27 31 34 120
’24 26 28 29 28 111
’23 30 29 29 28 117
’22 35 37 34 33 139
’21 30 34 38 37 140
’20 22 20 32 32 105
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 4 7 6 — —
’25 5 7 7 9 29
’24 4 4 7 5 21
’23 1 6 4 4 15
’22 3 5 7 6 21
’21 1 1 5 6 13
’20 (4) 1 (1) 3 (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 2 6 6 — —
’25 4 5 6 6 21
’24 2 3 5 3 13
’23 (2) 3 1 1 4
’22 0 2 3 3 9
’21 (1) (1) 3 3 3
’20 (6) 0 (3) 1 (9)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 24 32 51 64 105 140 139 117 111 120 131 +19.4% 130 143 — +8.9%
Gross margin, % 45.22 44.42 38.17 36.09 38.34 37.74 39.18 39.50 45.11 46.51 47.22 +1.3 pt
EBT (9) (5) (2) (1) (9) 3 6 (49) 8 11 10 n/m
EBT margin, % (35.11) (17.28) (4.54) (1.05) (8.29) 2.14 4.04 (41.89) 7.23 9.13 7.63 +44.2 pt
Net income (9) (6) (2) (1) (9) 3 5 (49) 8 11 10 n/m
Per share, $
Per share, $ Revenue 2.44 2.89 4.31 5.33 8.29 9.60 9.19 7.47 6.86 3.19 3.09 +3.0%
Earnings (0.95) (0.69) (0.59) (0.60) (1.79) (0.77) (0.67) (4.11) (0.28) 0.10 0.13 n/m
Cash flow (0.09) 0.03 0.58 0.63 (0.07) 0.92 1.40 0.99 1.28 0.76 0.59 n/m
Capex (0.05) (0.06) (0.09) (0.21) (0.61) (0.73) (0.78) (0.74) (0.46) (0.21) 0.00 +18.5%
Free cash flow (0.13) (0.04) 0.49 0.42 (0.68) 0.19 0.62 0.25 0.82 0.54 0.59 n/m
Book value 0.70 1.84 3.32 3.54 7.99 6.73 6.73 2.66 3.08 1.57 0.53 +9.4%
Shares, m 10 11 12 12 13 15 15 16 16 38 41 +15.9%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 36.50 16.54 3.7
P/S 0.27 0.92 0.88 0.76 1.09 0.66 0.30 0.24 0.53 0.92 0.70 0.7
P/B 0.94 1.44 1.15 1.15 1.14 0.94 0.41 0.67 1.19 1.85 4.04 1.1
EV/Sales 0.49 0.85 0.64 0.48 0.91 0.66 0.28 0.31 0.51 0.91 0.97 0.6
EV/FCF (8.88) (64.81) 5.58 6.16 (11.12) 33.06 4.20 9.51 4.23 5.32 7.10 (1.7)
Cash, $m
Cash, $m Operating cash flow (1) 0 7 8 (1) 13 21 15 21 29 25 n/m
Capex 0 (1) (1) (3) (8) (11) (12) (12) (7) (8) (7) +37.3%
Free cash flow (1) 0 6 5 (9) 3 9 4 13 21 25 n/m
Balance, $m
Balance, $m Working capital (7) 5 18 20 16 6 12 0 5 1 (4) n/m
Net debt 5 (4) (14) (20) (21) (2) (4) 7 (5) (3) (5) n/m
Shareholders’ equity 7 20 39 43 101 98 102 42 50 60 23 +26.7%
Returns, %
Returns, % ROA (34.72) (28.21) (19.04) (13.95) (23.34) (8.04) (7.28) (60.14) (5.97) 4.89 6.13 +39.6 pt
ROIC (39.64) (17.65) (6.45) 0.18 (6.43) 2.31 4.24 (60.81) 12.77 12.59 43.62 +52.2 pt
ROE (86.98) (55.61) (23.55) (17.77) (31.50) (11.26) (10.10) (89.75) (9.75) 7.12 13.55 +94.1 pt
People
People Employees 2,050 1,700 2,400 2,700 3,700 4,100 4,150 3,600 3,650 3,650 — +6.6%
Revenue/emp, $m 0.01 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.03 — +12.0%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

CareCloud, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
AMWL American Well Corporation $208.5M — (loss-making) — (loss-making) −12.96% (below 0%: shrinking) n/m +21.98% (above 0%: growing) 52.99% (23.79%) Compare
SY So-Young International Inc. Sponsored ADR $177.7M — (loss-making) 12.8× +40.84% (above 0%: growing) n/m −798.37% (below 0%: shrinking) 44.11% (8.64%) Compare
DH Definitive Healthcare Corp. $163.7M — (loss-making) — (loss-making) −8.99% (below 0%: shrinking) n/m −32.60% (below 0%: shrinking) 77.27% (9.09%) Compare
OPRX OptimizeRx Corp. $163.3M 35.8× 41.7× −29.77% (below 0%: shrinking) n/m +89.86% (above 0%: growing) 76.51% (0.43%) Compare
HCAT Health Catalyst, Inc. $112.9M — (loss-making) — (loss-making) −26.26% (below 0%: shrinking) n/m +65.58% (above 0%: growing) 42.71% 89.08% Compare
LFMD LifeMD, Inc. $110.4M — (loss-making) — (loss-making) −3.55% (below 0%: shrinking) n/m −247.52% (below 0%: shrinking) 88.82% (15.08%) Compare
CCLD CareCloud, Inc. $91.8M 16.5× 11.0× +8.56% (above 0%: growing) +150.00% (above 0%: growing) −0.44% (below 0%: shrinking) 50.46% 19.50%
DRIO DarioHealth Corp. $26.7M — (loss-making) — (loss-making) −3.58% (below 0%: shrinking) n/m −0.74% (below 0%: shrinking) 61.66% (125.15%) Compare
ONMD OneMedNet Corporation $25.1M — (loss-making) — +88.39% (above 0%: growing) n/m +14.05% (above 0%: growing) (193.49%) (774.32%) Compare
Median of peers $138.1M — — −6.28% — +6.66% 57.33% (12.08%)

All 44 Health Information Services stocks →

Pay and ownership Proxy statement filed 7 April 2026

Ownership

Directors and executive officers, together 4.40%
Mahmud Haq, Executive Chairman 0.80%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

CareCloud, Inc. (CCLD) Latest News

6 Nov

Impact 3 · · GuruFocus.com

5 Nov

Impact 3 · · The Motley Fool transcript
Impact 3 · · MarketBeat
Impact 3 · · GlobeNewswire

27 Oct

Impact 4 · · GlobeNewswire

22 Oct

Impact 3 · · Insider Monkey

29 Sep

Impact 4 ·

18 Aug

Impact 4 ·

13 Aug

Impact 4 · · The Motley Fool transcript

7 Aug

Impact 4 ·

6 Aug

Impact 4 ·
Impact 3 · · Moby transcript
Impact 3 · · MarketBeat
Impact 3 ·

26 May

Impact 4 · · GlobeNewswire

21 May

Impact 4 · · GlobeNewswire

18 May

Impact 3 · · GlobeNewswire

15 May

Impact 4 · · Simply Wall St.

11 May

Impact 4 · · Zacks Small Cap Research
Impact 3 · · Simply Wall St.

8 May

Impact 3 · · Moby transcript

7 May

Impact 4 · · MarketBeat
Impact 4 · · GlobeNewswire
Impact 3 · · Zacks

1 May

Impact 4 ·

30 Apr

Impact 3 · · Zacks

16 Apr

Impact 4 · · GlobeNewswire

14 Apr

Impact 4 · · GlobeNewswire

30 Mar

Impact 4 · · GlobeNewswire

18 Mar

Impact 4 · · GlobeNewswire
stockrow.com/CCLD · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com